Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate
Kev Lag Luam Kev Lag Luam PF-07321332 Paxlovid Cov Khoom Siv Hluav Taws Xob nrog Cov Khoom Zoo
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
Tom ntej: 6,6-Dimethyl-3-azabicyclo [3.1.0]hexane CAS 943516-54-9
Tshuaj npe | Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate |
Synonyms | Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate;(αS,3S)-α-[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate |
CAS Nr | 328086-60-8 |
CAT Number | Qauv: RF-PI317 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale nce mus txog pua pua ntawm Kilograms |
Molecular Formula | C13H22N2O5 |
Molecular Luj | 286.33 Nws |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Powder |
Kev Taw Qhia A | IR: Zoo ib yam li Cov Khoom Siv |
Kev Qhia B | Lub Sijhawm Khaws Cia: Zoo ib yam li Cov Khoom Siv |
Poob rau ziab | ≤ 1.0% |
Residue ntawm Ignition | ≤ 0.20% |
Ib leeg Impurity | ≤0.50% |
Tag nrho cov impurities | ≤ 2.0% |
Heavy Metals (Pb) | ≤ 20ppm |
Purity | ≥98.0% |
Test Standard | Enterprise Standard |
Kev siv | Intermediate ntawm PF-07321332 Paxlovid (CAS 2628280-40-8) thiab Boceprevir (CAS 394730-60-0) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate (CAS 328086-60-8) yog nruab nrab ntawm PF-07321332 Paxlovid (CAS 2628280-40) -8) thiab Boceprevir (CAS 394730-60-0).PF-07321332, lub ntsiab lus tseem ceeb ntawm Paxlovid (PF-07321332 thiab Ritonavir) uas yog tus kws tshawb nrhiav COVID-19 qhov ncauj tshuaj tiv thaiv tus neeg sib tw, yog qhov ncauj qhov ncauj bioavailable 3C-zoo li protease (3CLPRO) inhibitor nrog cov tshuaj tiv thaiv muaj zog tiv thaiv kab mob SARS-CoV-2. thiab COVID-19.Thaum Lub Kaum Ib Hlis 6th 2021, Pfizer tshaj tawm tias Paxlovid txo qis kev mus pw hauv tsev kho mob thiab kev tuag, raws li kev soj ntsuam ib ntus ntawm Theem 2/3 EPIC-HR (Kev Ntsuam Xyuas ntawm Protease Inhibition rau COVID-19 hauv Cov Neeg Mob Risk Siab) randomized, ob qhov muag tsis pom kev. ntawm cov neeg laus uas tsis nyob hauv tsev kho mob nrog COVID-19, uas muaj kev pheej hmoo siab ua rau mob hnyav.Boceprevir (EBP-520) yog HCV protease inhibitor (Ki = 14 nM) rau kev kho tus kab mob siab C.Boceprevir nrog pegylated interferon thiab ribavirin (PegIFN / RBV) tau ua kom muaj kev txhim kho hauv cov kab mob kis tau zoo ntawm cov neeg mob genotype 1 HCV.Boceprevir cuam tshuam nrog kev siv tshuaj tiv thaiv kab mob (IT) los ntawm inhibiting cytochrome P450 3A enzyme.